News-Medical.Net on MSN
DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
Vivere Oncotherapies, a UC Berkeley spin-out developing cancer therapies that activate the immune system to detect and destroy cancer cells in immunologically cold tumors, today announced over $10M in ...
News Medical on MSN
Autologous T cell therapy targeting multiple antigens shows promise treating pancreatic cancer
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
Many advanced cancers develop resistance to treatment and become highly aggressive, often leaving patients with limited treatment options. In some cancers, including lung, pancreatic and prostate ...
A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...
Scientists at UCLA have developed an “off-the-shelf” cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs. In a mouse study, ...
For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before the cancer comes back. Researchers at UCLA have found that a blend of a ...
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback